MedPath

Insel Gruppe AG

Insel Gruppe AG logo
🇨🇭Switzerland
Ownership
Private
Established
2016-01-01
Employees
10K
Market Cap
-
Website
https://www.inselgruppe.ch

Functional Residual Capacity Under Apnoeic Oxygenation With Different Flow Rates in Children

Not Applicable
Completed
Conditions
Apnea Infant
Intubation Complication
Children, Only
Apnea
Ventilation Therapy; Complications
Anesthesia
Atelectasis
Interventions
Other: 4 L/kg/min, FiO2 1.0 + continuous jaw thrust
Other: 2 L/kg/min using OptiFlow-Switch system, FiO2 1.0 + continuous jaw thrust
Other: 2 L/kg/min, FiO2 1.0 + continuous jaw thrust
Other: 0.2 L/kg/min, FiO2 1.0 + continuous jaw thrust
First Posted Date
2023-01-05
Last Posted Date
2024-05-08
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
108
Registration Number
NCT05672329
Locations
🇨🇭

Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Parental Involvement in Pain Reducing Measures

Not Applicable
Completed
Conditions
Procedural Pain
Parents
Preterm Infants
Interventions
Radiation: Active parental involvement
Behavioral: Passive parental involvement
First Posted Date
2022-12-19
Last Posted Date
2022-12-19
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
20
Registration Number
NCT05656677
Locations
🇨🇭

Inselspital, Bern, Switzerland

Baldachin: Ceiling HEPA-filtration to Prevent Nosocomial Transmission of COVID-19

Not Applicable
Recruiting
Conditions
COVID-19
Interventions
Device: Baldachin
First Posted Date
2022-12-13
Last Posted Date
2023-12-06
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
104
Registration Number
NCT05648097
Locations
🇨🇭

Inselspital Bern University Hospital, Bern, Canton Of Bern, Switzerland

An INtervention TO Improve MOBility of Older Hospitalized Patients

Not Applicable
Recruiting
Conditions
Hospital Mobility
Life-Space
Mobility Limitation
Functional Status
Muscle Atrophy or Weakness
Hospital-Acquired Condition
Sarcopenia
Iatrogenic Disease
Interventions
Behavioral: INTOMOB intervention
First Posted Date
2022-12-06
Last Posted Date
2024-03-28
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
294
Registration Number
NCT05639231
Locations
🇨🇭

Inselspital, Bern University Hospital, InselGruppe AG, Bern, Switzerland

🇨🇭

Spital Tiefenau, InselGruppe AG, Bern, Switzerland

🇨🇭

HFR-Fribourg - hôpital cantonal, Villars-sur-Glâne, Fribourg, Switzerland

and more 1 locations

Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients

Phase 2
Recruiting
Conditions
Multiple Myeloma
Interventions
First Posted Date
2022-12-05
Last Posted Date
2024-07-08
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
120
Registration Number
NCT05636787
Locations
🇨🇭

Departement of Medical Oncology, University Hospital Berne, Berne, Switzerland

Intracoronary ECG ST-segment Shift Remission Time During Reactive Coronary Hyperemia

Recruiting
Conditions
Chronic Coronary Syndrome
First Posted Date
2022-10-18
Last Posted Date
2022-10-21
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
120
Registration Number
NCT05583786
Locations
🇨🇭

Inselspital, Bern, Switzerland

The HypoVoice Study

Not Applicable
Completed
Conditions
Hypoglycemia
Diabetes Mellitus
Interventions
Other: Controlled hypoglycemic state
First Posted Date
2022-10-06
Last Posted Date
2023-03-10
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
7
Registration Number
NCT05569876
Locations
🇨🇭

Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern, Switzerland

Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers

Completed
Conditions
Multiple Sclerosis
Interventions
Other: Voice analysis
First Posted Date
2022-09-30
Last Posted Date
2023-06-15
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
70
Registration Number
NCT05561621
Locations
🇨🇭

Inselspital University Hospital Bern, Bern, Switzerland

The FibreGum Study - Changing the Course of Obesity in Children

Not Applicable
Recruiting
Conditions
Nutritional and Metabolic Diseases
Child Obesity
Adolescent Obesity
Interventions
Dietary Supplement: Placebo
Dietary Supplement: FibreGum
First Posted Date
2022-09-15
Last Posted Date
2025-01-24
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
105
Registration Number
NCT05540678
Locations
🇨🇭

Kinderklinik Bern, Berne, Switzerland

🇨🇭

Ostschweizer Kinderspital, St. Gallen, Switzerland

SINGLE SHOT CHAMPION

Phase 4
Active, not recruiting
Conditions
Paroxysmal Atrial Fibrillation
Interventions
Device: PVI using the Arctic Front Cryoballoon (Medtronic)
Device: PVI using FARAPULSE Pulsed Field Ablation (Boston Scientific)
First Posted Date
2022-09-09
Last Posted Date
2025-02-19
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
210
Registration Number
NCT05534581
Locations
🇨🇭

Inselspital, Bern University Hospital, Bern, Switzerland

🇨🇭

University Hospital Basel, Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath